https://en.people.cn/n3/2025/1017/c90000-20378483.html

Brain-computer interface, or BCI, technology enables interaction between biological and machine intelligence by building information channels between the human brain and machines. It can capture the brain’s signals of ‘intent to move’, assisting movement through exoskeletons or functional electrical stimulation.

In August 2025, multiple Chinese authorities jointly issued a set of guidelines aimed at promoting the innovative development of the BCI industry, including calls for the accelerated adoption of brain-computer interface products across sectors such as industrial manufacturing, healthcare and consumption by 2027. The National Medical Products Administration released China’s first standards for BCI medical devices in September.

The establishment of BCI outpatient clinics will provide a standardized and professional channel for consultation and assessment to patients with real needs. BCI’s clinical application is still in a very early exploratory stage, Technologically, both invasive and noninvasive methods face bottlenecks such as signal stability, long-term biocompatibility and the accuracy of decoding algorithms. Surgical risks, data privacy and complex ethical issues are still hurdles that must be overcome before large-scale promotion can occur.